Reduced membrane lipids in the cortex of alzheimer's disease transgenic mice

Jeffrey K. Yao, Thomas M. Wengenack, Geoffry L. Curran, Joseph F. Poduslo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Accumulating evidence suggests that the conversion of Aβ peptides to soluble, neurotoxic polymers is the key event in the development of Alzheimer's disease (AD). Moreover, interactions between Aβ peptides and neuronal membrane lipids likely play a vital role in developing the neurotoxicity associated with AD. The aim of this study is to assess whether lipid matrix of neuronal membranes is affected by the accumulation of Aβ peptides in double transgenic mouse model of AD expressing both mutant human β-amyloid precursor protein (APP) and presenilin 1 (PS1). We apply high pressure liquid chromatography with an evaporative light scattering detector to compare levels of cholesterol, galactocerebrosides, and phospholipid subclasses simultaneously in cortex samples between AD double transgenic mice at 4 months of age when Aβ production and amyloid plaque deposition is just beginning and at 9 months, when there is advanced Aβ levels and plaque deposition compared to age-matched wild-type (B6/SJL) mice. Both cholesterol (CL) and phospholipids (PL) are significantly lower in 9-month-old AD mice than the same age of B6/SJL mice. Among PL subclasses, phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylcholine (PC) are selectively reduced in 9-month-old AD mice. The molar ratios of CL to PL in 9-month-old AD mice (1.19 ± 0.27) were significantly higher than those of 9-month-old B6/SJL mice (0.81 ± 0.08). In keeping with decreased levels of PL, there are also significant reductions of very long-chain n-3 fatty acids (docosahexaenoic acid) and n-6 fatty acid (arachidonic acid) in 9-month-old AD mice. On the other hand, ratios of total n-6 to total n-3 fatty acids were significantly higher in 9-month-old AD mice than in the same age of B6/SJL mice. Taken together, our present data support a role for the interactions of amyloid-β peptide and neuronal membranes in the subsequent development of AD.

Original languageEnglish (US)
Pages (from-to)102-108
Number of pages7
JournalNeurochemical Research
Volume34
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Membrane Lipids
Transgenic Mice
Alzheimer Disease
Phospholipids
Peptides
Cholesterol
Omega-3 Fatty Acids
Amyloid
High pressure liquid chromatography
Galactosylceramides
Presenilin-1
Membranes
Docosahexaenoic Acids
Amyloid beta-Protein Precursor
Phosphatidylserines
Amyloid Plaques
Phosphatidylcholines
Arachidonic Acid
Light scattering
Polymers

Keywords

  • Alzheimer's disease
  • Cortex
  • Double transgenic mice
  • Lipids
  • Polyunsaturated fatty acids

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Reduced membrane lipids in the cortex of alzheimer's disease transgenic mice. / Yao, Jeffrey K.; Wengenack, Thomas M.; Curran, Geoffry L.; Poduslo, Joseph F.

In: Neurochemical Research, Vol. 34, No. 1, 01.2009, p. 102-108.

Research output: Contribution to journalArticle

Yao, Jeffrey K. ; Wengenack, Thomas M. ; Curran, Geoffry L. ; Poduslo, Joseph F. / Reduced membrane lipids in the cortex of alzheimer's disease transgenic mice. In: Neurochemical Research. 2009 ; Vol. 34, No. 1. pp. 102-108.
@article{d67a5bf089954b099ac8f4eb9a424e77,
title = "Reduced membrane lipids in the cortex of alzheimer's disease transgenic mice",
abstract = "Accumulating evidence suggests that the conversion of Aβ peptides to soluble, neurotoxic polymers is the key event in the development of Alzheimer's disease (AD). Moreover, interactions between Aβ peptides and neuronal membrane lipids likely play a vital role in developing the neurotoxicity associated with AD. The aim of this study is to assess whether lipid matrix of neuronal membranes is affected by the accumulation of Aβ peptides in double transgenic mouse model of AD expressing both mutant human β-amyloid precursor protein (APP) and presenilin 1 (PS1). We apply high pressure liquid chromatography with an evaporative light scattering detector to compare levels of cholesterol, galactocerebrosides, and phospholipid subclasses simultaneously in cortex samples between AD double transgenic mice at 4 months of age when Aβ production and amyloid plaque deposition is just beginning and at 9 months, when there is advanced Aβ levels and plaque deposition compared to age-matched wild-type (B6/SJL) mice. Both cholesterol (CL) and phospholipids (PL) are significantly lower in 9-month-old AD mice than the same age of B6/SJL mice. Among PL subclasses, phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylcholine (PC) are selectively reduced in 9-month-old AD mice. The molar ratios of CL to PL in 9-month-old AD mice (1.19 ± 0.27) were significantly higher than those of 9-month-old B6/SJL mice (0.81 ± 0.08). In keeping with decreased levels of PL, there are also significant reductions of very long-chain n-3 fatty acids (docosahexaenoic acid) and n-6 fatty acid (arachidonic acid) in 9-month-old AD mice. On the other hand, ratios of total n-6 to total n-3 fatty acids were significantly higher in 9-month-old AD mice than in the same age of B6/SJL mice. Taken together, our present data support a role for the interactions of amyloid-β peptide and neuronal membranes in the subsequent development of AD.",
keywords = "Alzheimer's disease, Cortex, Double transgenic mice, Lipids, Polyunsaturated fatty acids",
author = "Yao, {Jeffrey K.} and Wengenack, {Thomas M.} and Curran, {Geoffry L.} and Poduslo, {Joseph F.}",
year = "2009",
month = "1",
doi = "10.1007/s11064-008-9673-1",
language = "English (US)",
volume = "34",
pages = "102--108",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Reduced membrane lipids in the cortex of alzheimer's disease transgenic mice

AU - Yao, Jeffrey K.

AU - Wengenack, Thomas M.

AU - Curran, Geoffry L.

AU - Poduslo, Joseph F.

PY - 2009/1

Y1 - 2009/1

N2 - Accumulating evidence suggests that the conversion of Aβ peptides to soluble, neurotoxic polymers is the key event in the development of Alzheimer's disease (AD). Moreover, interactions between Aβ peptides and neuronal membrane lipids likely play a vital role in developing the neurotoxicity associated with AD. The aim of this study is to assess whether lipid matrix of neuronal membranes is affected by the accumulation of Aβ peptides in double transgenic mouse model of AD expressing both mutant human β-amyloid precursor protein (APP) and presenilin 1 (PS1). We apply high pressure liquid chromatography with an evaporative light scattering detector to compare levels of cholesterol, galactocerebrosides, and phospholipid subclasses simultaneously in cortex samples between AD double transgenic mice at 4 months of age when Aβ production and amyloid plaque deposition is just beginning and at 9 months, when there is advanced Aβ levels and plaque deposition compared to age-matched wild-type (B6/SJL) mice. Both cholesterol (CL) and phospholipids (PL) are significantly lower in 9-month-old AD mice than the same age of B6/SJL mice. Among PL subclasses, phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylcholine (PC) are selectively reduced in 9-month-old AD mice. The molar ratios of CL to PL in 9-month-old AD mice (1.19 ± 0.27) were significantly higher than those of 9-month-old B6/SJL mice (0.81 ± 0.08). In keeping with decreased levels of PL, there are also significant reductions of very long-chain n-3 fatty acids (docosahexaenoic acid) and n-6 fatty acid (arachidonic acid) in 9-month-old AD mice. On the other hand, ratios of total n-6 to total n-3 fatty acids were significantly higher in 9-month-old AD mice than in the same age of B6/SJL mice. Taken together, our present data support a role for the interactions of amyloid-β peptide and neuronal membranes in the subsequent development of AD.

AB - Accumulating evidence suggests that the conversion of Aβ peptides to soluble, neurotoxic polymers is the key event in the development of Alzheimer's disease (AD). Moreover, interactions between Aβ peptides and neuronal membrane lipids likely play a vital role in developing the neurotoxicity associated with AD. The aim of this study is to assess whether lipid matrix of neuronal membranes is affected by the accumulation of Aβ peptides in double transgenic mouse model of AD expressing both mutant human β-amyloid precursor protein (APP) and presenilin 1 (PS1). We apply high pressure liquid chromatography with an evaporative light scattering detector to compare levels of cholesterol, galactocerebrosides, and phospholipid subclasses simultaneously in cortex samples between AD double transgenic mice at 4 months of age when Aβ production and amyloid plaque deposition is just beginning and at 9 months, when there is advanced Aβ levels and plaque deposition compared to age-matched wild-type (B6/SJL) mice. Both cholesterol (CL) and phospholipids (PL) are significantly lower in 9-month-old AD mice than the same age of B6/SJL mice. Among PL subclasses, phosphatidylethanolamine (PE), phosphatidylserine (PS) and phosphatidylcholine (PC) are selectively reduced in 9-month-old AD mice. The molar ratios of CL to PL in 9-month-old AD mice (1.19 ± 0.27) were significantly higher than those of 9-month-old B6/SJL mice (0.81 ± 0.08). In keeping with decreased levels of PL, there are also significant reductions of very long-chain n-3 fatty acids (docosahexaenoic acid) and n-6 fatty acid (arachidonic acid) in 9-month-old AD mice. On the other hand, ratios of total n-6 to total n-3 fatty acids were significantly higher in 9-month-old AD mice than in the same age of B6/SJL mice. Taken together, our present data support a role for the interactions of amyloid-β peptide and neuronal membranes in the subsequent development of AD.

KW - Alzheimer's disease

KW - Cortex

KW - Double transgenic mice

KW - Lipids

KW - Polyunsaturated fatty acids

UR - http://www.scopus.com/inward/record.url?scp=58149465620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149465620&partnerID=8YFLogxK

U2 - 10.1007/s11064-008-9673-1

DO - 10.1007/s11064-008-9673-1

M3 - Article

C2 - 18373196

AN - SCOPUS:58149465620

VL - 34

SP - 102

EP - 108

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 1

ER -